TFA
CERE
Toth Financial Advisory’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30
| Closed | -$954 | – | 852 |
|
|
2023
Q2 | $954 | Hold |
30
| – | – | ﹤0.01% | 728 |
|
|
2023
Q1 | $732 | Hold |
30
| – | – | ﹤0.01% | 758 |
|
|
2022
Q4 | $946 | Hold |
30
| – | – | ﹤0.01% | 663 |
|
|
2022
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 725 |
|
|
2022
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 678 |
|
|
2022
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 695 |
|
|
2021
Q4 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 725 |
|